Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

A look at the critical business issues companies need to address when developing medical devices.  
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Report: Medtronic looks longingly at China

May 27, 2015 by Fink Densford

Medtronic is reportedly looking to grow its presence in China with lower-cost devices, as well as search the Chinese domestic market for possible acquisitions.

Medtronic looks to expand Chinese presence

Medtronic (NYSE:MDT) is reportedly looking to actively expand its low-cost medical device presence in China, as well as searching the domestic medical-device market for possible acquisitions.

China investigates former top health official

May 27, 2015 by MassDevice

China is investigating a former top healthcare official on suspicion of bribery.

YYmeta

(Reuters) — China is investigating the former head of a healthcare ministry unit responsible for drug trials and leading implementation of healthcare policy for bribery, a prosecutor said yesterday.

A court in Sichuan province said it was investigating Wang Yu, the former top official at the Bureau of Medical Administration, as part of a crackdown on corruption in the healthcare sector.

VertiFlex wins FDA nod for Superion spine device

May 27, 2015 by Fink Densford

VertiFlex says it won pre-market approval from the FDA for its Superion interspinous spacer.

VertiFlex wins FDA nod for Superion

VertiFlex said today that it won pre-market approval from the FDA for its Superion interspinous spacer for treating moderate lumbar spinal stenosis.

Medtech startups outsource R&D

May 27, 2015 by Scott Wooldridge

Small medtech companies are finding value in outsourcing their research & development functions, according to a panel at a LifeScience Alley conference last week.

Medtech startups outsource R&D

Starting a medtech company comes with a host of challenges, from regulation to financing to reimbursement. One way that companies can overcome those challenges, according to 2 industry experts, is to outsource some of the research and development work – and in the process, create a leaner, more flexible company.

FDA warns Signal Medical on unapproved hip implants

May 27, 2015 by Brad Perriello

The FDA sends a warning letter to Signal Medical, flagging it for making unapproved changes to its MicroSeal hip implants.

FDA warns Signal Medical on unapproved hip implants

The FDA flagged Signal Medical Corp. for selling a hip implant after making changes that weren't approved by the federal safety watchdog.

Study: Heart valve coatings prolong durability

May 27, 2015 by Brad Perriello

A study of replacement heart valves treated with calcification-reducing coatings shows that the coatings prolong valve durability.

Study: Heart valve coatings prolong durability

ConMed ripe for M&A | The week in medtech M&A

May 27, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: ConMed ripe for M&A spree; Baxter looks to growth post-Baxalta spinout; Sorin shareholders OK Cyberonics Merger

Analyst: ConMed ripe for M&A spree

May 19, 2015 by Fink Densford

Analyst: ConMed ripe for M&A spree

Mela Sciences recalls MelaFind

May 27, 2015 by Fink Densford

Mela Sciences recalls its flagship MelaFind melanoma diagnosis system because some of its software wasn't included in its FDA approval.

Mela Sciences recalls MelaFind device

Mela Sciences (NSDQ:MELA) recalled its flagship MelaFind melanoma diagnosis aid because some of its software wasn't included in its pre-market approval from the FDA.